SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $17,201,235 |
| Positions | 2 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | RXRX | CL A | $14,500,687 | 3,951,141 |
| IonQ, Inc. | IONQ | CL A | $2,700,548 | 50,705 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.